CD274 and diffuse large B-cell lymphoma: Being consistent with Kiyasu and colleagues’[31] study, our data also revealed that PD-L1 expression was correlated with worse clinical outcome although it is not an independent prognostic marker for patients’ OS in our study, which suggested that treatments targeting PD-L1 might benefit DLBCL patients.